Imodium Instant

Loperamide Hydrochloride, the active ingredient in Imodium Instant, is an opioid antidiarrheal presented as an oral dosage form for oral use. It treats acute diarrhea and travelers' diarrhea in adults and children, reducing stool frequency and improving consistency.

GNH USA supplies Imodium Instant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Instant belongs to the opioid antidiarrheal class and is used to manage diarrheal conditions.

Acute diarrhea: reduces stool frequency and improves stool consistency. Travelers' diarrhea: provides rapid symptom relief for individuals traveling to high‑risk regions. Gastroenteritis‑related diarrhea: helps control loose stools caused by infectious gastroenteritis.

Common Side Effects: - Constipation: reduced bowel movements may become infrequent. - Abdominal cramps: mild to moderate discomfort in the abdomen. - Nausea: occasional feeling of queasiness. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Severe constipation or ileus: risk of bowel obstruction requiring medical attention. - Allergic reactions: rash, hives, or swelling indicating hypersensitivity. - Cardiac arrhythmia: abnormal heart rhythm, especially when combined with QT‑prolonging agents.

Imodium Instant should be used with clinical judgment and awareness of specific safety considerations. - Dosage adjustment in hepatic impairment: reduce dose and monitor response. - Avoid in patients with known hypersensitivity to loperamide or excipients. - Use with caution in children under two years of age. - Do not use in bacterial dysentery, colitis, or when fever is present. - Monitor for signs of constipation or bowel obstruction. - Store at room temperature: keep in the original pack, protect from moisture.

Imodium Instant may interact with other medicines; awareness of interaction severity guides safe use. Major Interactions (Avoid): - Concomitant use with potent CYP3A4 inhibitors (e.g., ketoconazole) may increase loperamide plasma levels. - Co‑administration with other opioid agonists can enhance central nervous system depression. - Use with QT‑prolonging drugs may raise the risk of cardiac arrhythmia. Moderate Interactions (Monitor Closely): - CYP2C8 inhibitors (e.g., gemfibrozil) may raise loperamide concentrations. - Anticholinergic agents may increase the likelihood of constipation. - Combining with other antidiarrheal agents may cause excessive slowing of gut motility.